Search hospitals > California > Marysville
Fremont - Rideout Cancer Center
Claim this profileMarysville, California 95901
Global Leader in Thyroid Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
118 reported clinical trials
16 medical researchers
Summary
Fremont - Rideout Cancer Center is a medical facility located in Marysville, California. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Fremont - Rideout Cancer Center is involved with conducting 118 clinical trials across 255 conditions. There are 16 research doctors associated with this hospital, such as Edward J. Kim, Jonathan W. Riess, Mamta Parikh, and Joseph M. Tuscano.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Edward J. KimUniversity of California Davis Comprehensive Cancer Center1 year of reported clinical research
Studies Stomach Cancer
Studies Thyroid Cancer
33 reported clinical trials
70 drugs studied
Jonathan W. RiessUniversity of California Davis Comprehensive Cancer Center5 years of reported clinical research
Expert in Thyroid Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
33 drugs studied
Mamta ParikhUniversity of California Davis Comprehensive Cancer Center4 years of reported clinical research
Expert in Thyroid Cancer
Studies Bladder Cancer
21 reported clinical trials
36 drugs studied
Joseph M. TuscanoUniversity of California Davis Comprehensive Cancer Center5 years of reported clinical research
Expert in Lymphoma
Expert in B-Cell Lymphoma
22 reported clinical trials
45 drugs studied
Clinical Trials running at Fremont - Rideout Cancer Center
Lung Cancer
Breast Cancer
Thyroid Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Breast cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Bladder Cancer
Multiple Myeloma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fremont - Rideout Cancer Center?
Fremont - Rideout Cancer Center is a medical facility located in Marysville, California. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Fremont - Rideout Cancer Center is involved with conducting 118 clinical trials across 255 conditions. There are 16 research doctors associated with this hospital, such as Edward J. Kim, Jonathan W. Riess, Mamta Parikh, and Joseph M. Tuscano.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.